Cargando…
Pharmacy Compounded Medicines for Patients With Rare Diseases: Lessons Learned From Chenodeoxycholic Acid and Cholic Acid
Patients with rare diseases are often confronted with the fact that effective medicines are unavailable or simply not being developed. This situation jeopardizes the health of a large population of vulnerable patients with rare diseases. Pharmacy compounded formulations can provide a safe alternativ...
Autores principales: | Polak, Yasmin, Jacobs, Bart A. W., Kemper, E. Marleen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505773/ https://www.ncbi.nlm.nih.gov/pubmed/34650439 http://dx.doi.org/10.3389/fphar.2021.758210 |
Ejemplares similares
-
Product development and quality of pharmacy compounded chenodeoxycholic acid capsules for Dutch cerebrotendinous xanthomatosis patients
por: Bouwhuis, Natalja, et al.
Publicado: (2023) -
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects
por: Polak, Yasmin, et al.
Publicado: (2023) -
Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults
por: Cariou, Bertrand, et al.
Publicado: (2011) -
Investigation of α,ω-Disubstituted Polyamine-Cholic Acid Conjugates Identifies Hyodeoxycholic and Chenodeoxycholic Scaffolds as Non-Toxic, Potent Antimicrobials
por: Sue, Kenneth, et al.
Publicado: (2023) -
Influence of the gut microbiota on endometriosis: Potential role of chenodeoxycholic acid and its derivatives
por: Li, Yangshuo, et al.
Publicado: (2022)